The Brain's Financial System: A Game Theory of Dopamine, Serotonin, and the Lateral Habenula[大脑财务系统]

Abstract

Abstract Dopamine, serotonin, and the lateral habenula have long been mislabeled as the "pleasure molecule," "mood stabilizer," and "anti-reward center." These labels obscure a deeper truth: they constitute the brain's built-in decision-value evaluation system—a precise Brain Financial System. This book presents a unified framework that redefines the three systems as: · Dopamine = Benefit Expectation · Serotonin = Loss Expectation · Lateral Habenula = Cost Expectation Together, they report to the "CEO"—the prefrontal cortex—which computes Decision Net Value: Decision Net Value = Benefit Expectation − Loss Expectation − Cost Expectation If net value is positive, act; if negative, refrain; if near zero, hesitate. This formula is not a metaphor—it is a neural computation model supported by independent experimental evidence: dopamine reward prediction error (Schultz, 1997), serotonin loss assessment (Colwell, 2024; Neukam, 2018; ATD experiments), and lateral habenula cost accounting (Sevigny, 2021). The book further extends this framework to explain a range of phenomena: · The Buffett Threshold: the tipping point at which expected benefit exceeds expected loss, determining whether decisions lean toward risk-taking or conservatism; · The Anti-Fishing Circuit: when reward disappears, the lateral habenula triggers a healthy "stop investing" program (Post, 2022); · The Despair Circuit: when the lateral habenula becomes locked in burst-firing, cost signals are fixed at infinity, rendering net value negative for all options—the neural essence of learned helplessness (Yang, 2018); · The Serotonin No-Go Executor: serotonin, via 5-HT2C receptors, activates D2-MSNs to physically apply the brake at the action level (Malenka & Cardozo Pinto, 2026; Härmson, 2021); · The Dual-Baseline Theory: the tonic levels of dopamine and serotonin jointly determine emotional immunity, delayed gratification capacity, and decision stability. The book also applies this framework to explain social and pathological phenomena—the overjustification effect, involution, workplace apathetic disengagement, drug addiction, anxiety disorders, and depression—and discusses its practical implications for education, workplace management, business, and the boundaries of artificial intelligence. The brain is not a passive emotional machine—it is a holding company with its own Reward Department, Risk Department, and Cost Department. Understanding how this system operates is the starting point for understanding human decision-making—and when it fails. Keywords: Brain Financial System; dopamine; serotonin; lateral habenula; benefit expectation; loss expectation; cost expectation; decision net value; Buffett Threshold; Anti-Fishing Circuit; Despair Circuit; dual-baseline theory 中文摘要 多巴胺、血清素和外侧缰核被长期误解为“快乐分子”、“情绪稳定剂”和“反奖赏中心”。这些标签掩盖了一个更深层的真相:它们构成了大脑内置的决策价值评估系统——一个精密的大脑财务系统。 本书提出一个统一框架,将三个系统重新定义为: · 多巴胺 = 预期收益(Benefit Expectation) · 血清素 = 预期亏损(Loss Expectation) · 外侧缰核 = 预期成本(Cost Expectation) 三者共同向“CEO”——前额叶皮层——提交报告,由后者计算决策净价值: 决策净价值 = 预期收益 − 预期亏损 − 预期成本 净价值为正,行动;为负,放弃;接近零,犹豫。这个公式不是比喻,而是由多巴胺奖赏预测误差(Schultz, 1997)、血清素亏损评估(Colwell, 2024; Neukam, 2018; ATD实验)、外侧缰核成本核算(Sevigny, 2021)等独立实验证据支撑的神经计算模型。 本书进一步拓展这一框架,解释一系列现象: · 巴菲特阈值:预期收益超过预期亏损的临界点,决定决策倾向于冒险还是保守; · 反钓鱼回路:当奖赏消失时,外侧缰核触发“停止投入”的健康止损程序(Post, 2022); · 绝望回路:外侧缰核卡死时,成本信号被锁定为无穷大,所有选项净价值为负,构成习得性无助的神经本质(Yang, 2018); · 血清素 No-Go 执行器:血清素通过5-HT2C受体激活D2-MSNs,在动作层面直接踩刹车(Malenka & Cardozo Pinto, 2026; Härmson, 2021); · 双基线理论:多巴胺和血清素的紧张性(tonic)水平共同决定情绪免疫力、延迟满足能力和决策稳定性。 本书还应用该框架解释德西效应、内卷、职场淡漠式躺平、吸毒成瘾、焦虑症与抑郁症等社会与病理现象,并讨论其在教育、职场、商业以及人工智能边界方面的实践意义。 大脑不是一部被动反应的情绪机器,而是一家自带收益部、风控部和成本部的控股公司。理解这套系统的运作规则,是理解人类决策——以及它何时失效——的起点。 关键词:大脑财务系统;多巴胺;血清素;外侧缰核;预期收益;预期亏损;预期成本;决策净价值;巴菲特阈值;反钓鱼回路;绝望回路;双基线理论